Aviva PLC Abb Vie Inc. Transaction History

Aviva PLC

$28.3 Billion
Q1 2024

A detailed history of Aviva PLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Aviva PLC holds 769,808 shares of ABBV stock, worth $132 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares

769,808

Previous 739,192 4.14%

Holding current value

$132 Million

Previous $115 Million 22.37%

% of portfolio

0.49%

Previous 0.44%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$159.82 - $182.1 $4.89 Million - $5.58 Million	30,616 Added 4.14%	769,808 $140 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $603,100 - $679,233	4,383 Added 0.6%	739,192 $115 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $3.87 Million - $4.48 Million	28,958 Added 4.1%	734,809 $110 Million
Q2 2023 Aug 10, 2023	BUY	$132.51 - $164.9 $16.4 Million - $20.4 Million	123,802 Added 21.27%	705,851 $95.1 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $9.15 Million - $10.5 Million	-63,304 Reduced 9.81%	582,049 $92.8 Million

Q4 2022 Feb 09, 2023	BUY	$138.31 - $165.87 $13.4 Million - $16.1 Million	96,966 Added 17.68%	645,353 $104 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $4.5 Million - $5.16 Million	-33,551 Reduced 5.77%	548,387 $73.6 Million
Q2 2022 Aug 04, 2022	BUY	$137.62 - $174.96 $14.4 Million - $18.3 Million	104,770 Added 21.96%	581,938 $89.1 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $10.5 Million - $13 Million	-79,237 Reduced 14.24%	477,168 $77.4 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $9.49 Million - $12 Million	-88,324 Reduced 13.7%	556,405 $75.3 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.11 Million - $1.26 Million	-10,455 Reduced 1.6%	644,729 $69.5 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $2.79 Million - $3.11 Million	26,554 Added 4.22%	655,184 $73.8 Million
Q1 2021 May 13, 2021	SELL	$102.3 - $112.62 $20 Million - $22.1 Million	-195,805 Reduced 23.75%	628,630 $68 Million
Q4 2020 Feb 10, 2021	SELL	$80.49 - $108.67 $1.8 Million - $2.43 Million	-22,369 Reduced 2.64%	824,435 $88.3 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $2.29 Million - $2.69 Million	-26,712 Reduced 3.06%	846,804 $74.2 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $23.3 Million - $31.1 Million	317,148 Added 57.0%	873,516 $85.8 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $1.8 Million - $2.73 Million	27,945 Added 5.29%	556,368 $42.4 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $2.89 Million - $3.62 Million	-40,111 Reduced 7.06%	528,423 $46.8 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $2.63 Million - $3.16 Million	-41,780 Reduced 6.85%	568,534 $43.1 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $1.65 Million - $2.11 Million	-25,172 Reduced 3.96%	610,314 $44.4 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $122,421 - $144,083	1,587 Added 0.25%	635,486 $51.2 Million
Q4 2018 Feb 12, 2019	SELL	$77.85 - $96.01 $14.2 Million - $17.5 Million	-181,800 Reduced 22.29%	633,899 $58.4 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $6.51 Million - $7.23 Million	-73,165 Reduced 8.23%	815,699 $77.1 Million
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $1.02 Million - $1.21 Million	-11,353 Reduced 1.26%	888,864 $82.4 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $7.03 Million - $9.41 Million	-76,376 Reduced 7.82%	900,217 $85.2 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $15.6 Million - $17.1 Million	-173,667 Reduced 15.1%	976,593 $94.4 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $831,843 - $1.06 Million	11,909 Added 1.05%	1,150,260 $102 Million
Q2 2017 Aug 07, 2017	BUY	N/A	1,138,351	1,138,351 $82.5 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.

Account